BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DeAngelis RA, Reis ES, Ricklin D, Lambris JD. Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis. Immunobiology 2012;217:1097-105. [PMID: 22964235 DOI: 10.1016/j.imbio.2012.07.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Kohlová M, Amorim CG, Araújo A, Santos-silva A, Solich P, Montenegro MCBSM. The biocompatibility and bioactivity of hemodialysis membranes: their impact in end-stage renal disease. J Artif Organs 2019;22:14-28. [DOI: 10.1007/s10047-018-1059-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
2 Liu W, Fu X, Liu YF, Su T, Peng J. Vorapaxar-modified polysulfone membrane with high hemocompatibility inhibits thrombosis. Mater Sci Eng C Mater Biol Appl 2021;118:111508. [PMID: 33255066 DOI: 10.1016/j.msec.2020.111508] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Salvadè I, Del Giorno R, Gaetano D, Gabutti L. Assessing the contact-activation of coagulation during hemodialysis with three different polysulfone filters: A prospective randomized cross-over trial: Rating dialyzer coagulation activation. Hemodialysis International 2017;21:375-84. [DOI: 10.1111/hdi.12509] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
4 Ricklin D, Mastellos DC, Reis ES, Lambris JD. The renaissance of complement therapeutics. Nat Rev Nephrol 2018;14:26-47. [PMID: 29199277 DOI: 10.1038/nrneph.2017.156] [Cited by in Crossref: 196] [Cited by in F6Publishing: 183] [Article Influence: 39.2] [Reference Citation Analysis]
5 Davenport A. How can dialyzer designs improve solute clearances for hemodialysis patients?: Improving dialyzer designs. Hemodial Int 2014;18:S43-7. [DOI: 10.1111/hdi.12223] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
6 Zhao J, Hsiao S, Hsu M, Pao K, Kou YR, Shyue S, Lee T. Di-(2-ethylhexyl) phthalate accelerates atherosclerosis in apolipoprotein E-deficient mice. Arch Toxicol 2016;90:181-90. [DOI: 10.1007/s00204-014-1377-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
7 Fu X, Ning JP. Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis. J Mater Sci Mater Med 2018;29:66. [PMID: 29744595 DOI: 10.1007/s10856-018-6054-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Eloueyk AK, Alameddine RY, Osta BA, Awad DM. Correlations between serum inflammatory markers and comorbidities in patients with end-stage renal disease. J Taibah Univ Med Sci 2019;14:547-52. [PMID: 31908643 DOI: 10.1016/j.jtumed.2019.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Tangvoraphonkchai K, Riddell A, Davenport A. Platelet activation and clotting cascade activation by dialyzers designed for high volume online hemodiafiltration: Dialyzer platelet activation. Hemodialysis International 2018;22:192-200. [DOI: 10.1111/hdi.12586] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
10 Krieter DH, Jeyaseelan J, Rüth M, Lemke HD, Wanner C, Drechsler C. Clinical hemocompatibility of double-filtration lipoprotein apheresis comparing polyethersulfone and ethylene-vinyl alcohol copolymer membranes. Artif Organs 2021;45:1104-13. [PMID: 33617653 DOI: 10.1111/aor.13944] [Reference Citation Analysis]
11 Mödinger Y, Teixeira GQ, Neidlinger-Wilke C, Ignatius A. Role of the Complement System in the Response to Orthopedic Biomaterials. Int J Mol Sci 2018;19:E3367. [PMID: 30373272 DOI: 10.3390/ijms19113367] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
12 Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP. Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission. Clin Exp Immunol 2015;181:306-13. [PMID: 25079699 DOI: 10.1111/cei.12426] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
13 Mastellos DC, Ricklin D, Lambris JD. Clinical promise of next-generation complement therapeutics. Nat Rev Drug Discov 2019;18:707-29. [PMID: 31324874 DOI: 10.1038/s41573-019-0031-6] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 33.0] [Reference Citation Analysis]
14 Almeida A, Lourenço O, Fonseca AM. Haemodialysis in Diabetic Patients Modulates Inflammatory Cytokine Profile and T Cell Activation Status. Scand J Immunol 2015;82:135-41. [DOI: 10.1111/sji.12309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
15 Kizil M, Tengilimoglu-Metin MM, Gumus D, Sevim S, Turkoglu İ, Mandiroglu F. Dietary inflammatory index is associated with serum C-reactive protein and protein energy wasting in hemodialysis patients: A cross-sectional study. Nutr Res Pract 2016;10:404-10. [PMID: 27478547 DOI: 10.4162/nrp.2016.10.4.404] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
16 Ricklin D, Lambris JD. New milestones ahead in complement-targeted therapy. Semin Immunol 2016;28:208-22. [PMID: 27321574 DOI: 10.1016/j.smim.2016.06.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 10.7] [Reference Citation Analysis]
17 Morgan BP, Harris CL. Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov 2015;14:857-77. [PMID: 26493766 DOI: 10.1038/nrd4657] [Cited by in Crossref: 227] [Cited by in F6Publishing: 210] [Article Influence: 32.4] [Reference Citation Analysis]
18 Mastellos DC, Ricklin D, Hajishengallis E, Hajishengallis G, Lambris JD. Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention. Mol Oral Microbiol 2016;31:3-17. [PMID: 26332138 DOI: 10.1111/omi.12129] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
19 Talari HR, Zakizade M, Soleimani A, Bahmani F, Ghaderi A, Mirhosseini N, Eslahi M, Babadi M, Mansournia MA, Asemi Z. Effects of magnesium supplementation on carotid intima-media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2019;121:809-17. [PMID: 30739626 DOI: 10.1017/S0007114519000163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Reis ES, DeAngelis RA, Chen H, Resuello RR, Ricklin D, Lambris JD. Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters. Immunobiology. 2015;220:476-482. [PMID: 25468722 DOI: 10.1016/j.imbio.2014.10.026] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
21 Kościelska-Kasprzak K, Bartoszek D, Myszka M, Zabińska M, Klinger M. The complement cascade and renal disease. Arch Immunol Ther Exp (Warsz) 2014;62:47-57. [PMID: 24030732 DOI: 10.1007/s00005-013-0254-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
22 Mastellos DC, Reis ES, Biglarnia AR, Waldman M, Quigg RJ, Huber-Lang M, Seelen MA, Daha MR, Lambris JD. Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option? Clin Immunol 2019;198:102-5. [PMID: 30472267 DOI: 10.1016/j.clim.2018.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
23 Kourtzelis I, Rafail S, DeAngelis RA, Foukas PG, Ricklin D, Lambris JD. Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation. FASEB J. 2013;27:2768-2776. [PMID: 23558338 DOI: 10.1096/fj.12-225888] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
24 Wahrmann M, Mühlbacher J, Marinova L, Regele H, Huttary N, Eskandary F, Cohen G, Fischer GF, Parry GC, Gilbert JC, Panicker S, Böhmig GA. Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study. Am J Transplant 2017;17:2300-11. [PMID: 28251805 DOI: 10.1111/ajt.14256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
25 Bahramnezhad F, Asgari P, Zolfaghari M, Farokhnezhad Afshar P. Family-Centered Education and Its Clinical Outcomes in Patients Undergoing Hemodialysis Short Running. Iran Red Crescent Med J 2015;17:e20705. [PMID: 26290749 DOI: 10.5812/ircmj.17(5)2015.20705] [Reference Citation Analysis]
26 Stegmayr B, Willems C, Groth T, Martins A, Neves NM, Mottaghy K, Remuzzi A, Walpoth B. Arteriovenous access in hemodialysis: A multidisciplinary perspective for future solutions. Int J Artif Organs 2021;44:3-16. [PMID: 32438852 DOI: 10.1177/0391398820922231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Salimian M, Soleimani A, Bahmani F, Tabatabaei SMH, Asemi Z, Talari HR. The effects of selenium administration on carotid intima-media thickness and metabolic status in diabetic hemodialysis patients: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition ESPEN 2022;47:58-62. [DOI: 10.1016/j.clnesp.2021.11.022] [Reference Citation Analysis]
28 Poppelaars F, Faria B, Gaya da Costa M, Franssen CFM, van Son WJ, Berger SP, Daha MR, Seelen MA. The Complement System in Dialysis: A Forgotten Story? Front Immunol 2018;9:71. [PMID: 29422906 DOI: 10.3389/fimmu.2018.00071] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
29 Nørgaard I, Nielsen SF, Nordestgaard BG. Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study. Clinical Chemistry 2016;62:525-34. [DOI: 10.1373/clinchem.2015.251314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
30 Ferraz N, Mihranyan A. Is there a future for electrochemically assisted hemodialysis? Focus on the application of polypyrrole–nanocellulose composites. Nanomedicine 2014;9:1095-110. [DOI: 10.2217/nnm.14.49] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
31 Sun S, Zhao G, Liu C, Fan W, Zhou X, Zeng L, Guo Y, Kou Z, Yu H, Li J, Wang R, Li Y, Schneider C, Habel M, Riedemann NC, Du L, Jiang S, Guo R, Zhou Y. Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys. Clin Infect Dis 2015;60:586-95. [PMID: 25433014 DOI: 10.1093/cid/ciu887] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
32 Westphalen H, Abdelrasoul A, Shoker A. Protein adsorption phenomena in hemodialysis membranes: Mechanisms, influences of clinical practices, modeling, and challenges. Colloid and Interface Science Communications 2021;40:100348. [DOI: 10.1016/j.colcom.2020.100348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
33 Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol 2013;190:3831-8. [PMID: 23564577 DOI: 10.4049/jimmunol.1203487] [Cited by in Crossref: 288] [Cited by in F6Publishing: 276] [Article Influence: 32.0] [Reference Citation Analysis]
34 Ricklin D, Reis ES, Lambris JD. Complement in disease: a defence system turning offensive. Nat Rev Nephrol. 2016;12:383-401. [PMID: 27211870 DOI: 10.1038/nrneph.2016.70] [Cited by in Crossref: 248] [Cited by in F6Publishing: 246] [Article Influence: 41.3] [Reference Citation Analysis]
35 Poppelaars F, Gaya da Costa M, Faria B, Berger SP, Assa S, Daha MR, Medina Pestana JO, van Son WJ, Franssen CFM, Seelen MA. Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients. Front Immunol 2018;9:2070. [PMID: 30271407 DOI: 10.3389/fimmu.2018.02070] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]